Androgen Receptor Modulation Optimized for Response—Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7–expressing Metastatic Castration-resistant Prostate Cancer
Author:
Mary-Ellen Taplin,Emmanuel S. Antonarakis,Karen J. Ferrante,Kerry Horgan,Brent Blumenstein,Fred Saad,Jun Luo,Johann S. de Bono
Publication:
European Urology
© 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.